retatrutide mechanism triple agonist glp-1 gip glucagon Frontiers Dual and Triple Gut Peptide

This is a longer conversation and worth planning for before you get there, but knowing it exists takes the pressure off the climb

Discussion Our findings demonstrate that GLP-1 receptor-based therapeutics significantly disrupt the interoceptive stimulus effects of alcohol, highlighting a potential therapeutic mechanism through which these medications may reduce alcohol consumption and motivation

This schedule provides appropriate medical oversight while ensuring that prescriptions remain safe and clinically effective long term

Intern Med

Novo has even been able to produce an oral formulation

This combination represents a promising therapeutic strategy for improving cardiovascular, renal, and metabolic outcomes in patients with T2DM